Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of dyslipidemia after coronary artery bypass grafting.

Current opinion in lipidology - 1 Aug 2000

Alaupovic P

Abstract excerpt

The results of serial angiographic studies and intervention trials in patients after coronary artery bypass artery grafting have provided ample evidence that abnormalities of the plasma lipoprotein system are one of the most significant risk factors for a rapid atherosclerotic attrition of saphenous vein grafts. In addition to confirming the well recognized role and contribution of cholesterol-rich LDL or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Arteriosclerosis

Share to Clinical Trials as Topic

Share to Coronary Artery Bypass

Share to Hyperlipidemias

Share to Phenotype

Source

Identifiers

PMID: 10945718
DOI: 10.1097/00041433-200008000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Management of dyslipidemia after coronary artery bypass grafting.PMID 10945718Read ↗

Aggressive medical therapy for the prevention and treatment of coronary artery disease.Semantic proximity Read ↗

Optimal management of familial hypercholesterolemia: treatment and management strategiesSemantic proximity Read ↗

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases.Semantic proximity Read ↗

An internist's update on cholesterol management.Semantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and managementSemantic proximity Read ↗

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Semantic proximity Read ↗

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.